We’ve developed two member-only briefing documents to help you educate physicians and other prescribers abour compounding. One is “The Truth About Pharmacy Compounding;” the other is “Compounding Peptides: It’s Complicated.”
We’ve launched a portal to help our members aggregate patient-reported outcomes to demonstrate that compounded medications are benefitting millions of patients.
We’re working to save compounded hormones – therapies that benefit millions of Americans – in the wake of implicit threats to restrict them. Learn more about our campaign at compounding.com.
Via our Legal Action Fund, we’ve filed two recent amicus briefs in court cases, one defending compounders’ right to compound methylcobalamin and another addressing ambiguity in FDA’s insanitary conditions guidance.
We’re proposing to TRICARE a pilot project to demonstrate that compounded medications can help the agency achieve desired health outcomes and contain costs.
We’re talking with FDA about the practical flaws in its “final” GFI 256 on veterinary compounding—flaws that may impede animal healthcare.
We’re developing a “decision points document” to assist state boards of pharmacy in implementing and enforcing USP 800.
We’re advocating for eliminating the 25-year-old MOU, mandating reporting to state regulators by pharmacies that ship more than 50 percent of their compounded medications out of state, and creating a narrow path for 503As to provide much needed shortage drugs to hospitals and clinics.
We’re working with FDA and Congress to insist that compounding pharmacies’ 483 files be closed out within a more reasonable timeframe.
We’re providing our members access to an online payments platform that will integrate with the major compounding software.
We’ve launched a new Career Center to assist our members in recruiting qualified employees.
August 16, October 6: A joint APC/PCCA program, Quality & Compliance Webinar.
August 18: An APC Webinar: Hazardous Drug Decontamination – Understanding its Purpose and Validating Best Practices with Abby Roth
August 18–19: A joint APC/PCCA, in-person program, USP Implementation Training, Houston, TX
August 30: FDLI Drug Compounding Webinar, Updates and Developments in Drug Compounding
September 6–8: FDA’s virtual Compounding Quality Center of Excellence Annual Conference
September 14: APC’s Annual Meeting, 2:00-2:30pm ET, Hilton National Mall, Washington, DC
September 14–15: APC’s Compounders on Capitol Hill 2022, Hilton National Mall, Washington, DC
September 22: An APC Webinar: Keeping it Legit: Best Authentication Practices for Compounders, PART I – PROVIDERS AND PRESCRIPTIONS (registration link coming soon)
October 13: An APC Webinar: Keeping it Legit: Best Authentication Practices for Compounders, PART II – WHOLESALE DISTRIBUTORS (registration link coming soon)
October 26–29: PCCA’s International Seminar, Houston, TX (in-person + virtual)